Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes.
Emanuele MondaGiuseppe PalmieroMichele LioncinoMarta RubinoAnnapaola CirilloAdelaide FuscoMartina CaiazzaFederica VerrilloGaetano DianaAlfredo MaurielloMichele IavaroneMaria Angela LosiMaria Luisa De RiminiSanto Delle GrottaglieAntonello D'AndreaEduardo BossoneGiuseppe PacileoGiuseppe LimongelliPublished in: Journal of clinical medicine (2022)
Multimodality imaging is a comprehensive strategy to investigate left ventricular hypertrophy (LVH), providing morphologic, functional, and often clinical information to clinicians. Hypertrophic cardiomyopathy (HCM) is defined by an increased LV wall thickness not only explainable by abnormal loading conditions. In the context of HCM, multimodality imaging, by different imaging techniques, such as echocardiography, cardiac magnetic resonance, cardiac computer tomography, and cardiac nuclear imaging, provides essential information for diagnosis, sudden cardiac death stratification, and management. Furthermore, it is essential to uncover the specific cause of HCM, such as Fabry disease and cardiac amyloidosis, which can benefit of specific treatments. This review aims to elucidate the current role of multimodality imaging in adult patients with HCM.
Keyphrases